La Vecchia C, Lucchini F, Negri E, Levi F
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Int J Cancer. 1999 Mar 31;81(1):62-6. doi: 10.1002/(sici)1097-0215(19990331)81:1<62::aid-ijc12>3.0.co;2-2.
Trends in age-standardised death-certification rates for skin cancer [mainly cutaneous malignant melanoma (CMM)] over the period 1955-1995 were considered for 22 developed countries (18 from Europe, Canada, the United States, Australia and New Zealand) on the basis of the World Health Organization database. Between 1955 and 1984, mortality from CMM has been rising in both young adults (20 to 44 years) and middle aged population (45 to 64 years) in most European countries, North America and Australia. Between 1985 and 1995, CMM mortality rates were still rising in several countries for middle-aged males, though, to a lesser extent, they were more favourable in middle-aged women and declined in young adults in most countries, particularly in northern Europe.
基于世界卫生组织数据库，对1955年至1995年期间22个发达国家（18个来自欧洲、加拿大、美国、澳大利亚和新西兰）皮肤癌[主要是皮肤恶性黑色素瘤（CMM）]的年龄标准化死亡认证率趋势进行了研究。1955年至1984年期间，大多数欧洲国家、北美和澳大利亚的年轻成年人（20至44岁）和中年人群（45至64岁）的CMM死亡率一直在上升。1985年至1995年期间，几个国家中年男性的CMM死亡率仍在上升，不过，中年女性的情况相对较好，且大多数国家（尤其是北欧）的年轻成年人死亡率有所下降。
